Eli Lilly and Company (LLY)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 5,240,400 | 6,244,800 | 5,581,700 | 6,193,700 | 8,318,400 |
| Revenue | US$ in thousands | 34,124,100 | 28,541,400 | 28,318,400 | 24,539,800 | 22,319,500 |
| Net profit margin | 15.36% | 21.88% | 19.71% | 25.24% | 37.27% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $5,240,400K ÷ $34,124,100K
= 15.36%
The net profit margin of Lilly(Eli) & Co has been fluctuating over the past five years, as indicated by the data provided. In 2019, the company had a relatively high net profit margin of 37.27%, which may suggest strong profitability. However, there was a significant decrease in the net profit margin in 2020 to 25.24%, signaling a potential decline in profitability.
Subsequently, in 2021 and 2022, the net profit margin slightly increased to 19.71% and 21.88%, respectively, but remained below the levels seen in 2019. This may indicate efforts to improve profitability but not yet reaching previous peak levels.
Notably, in 2023, the net profit margin further decreased to 15.36%, which could raise concerns about the company's ability to generate profits relative to its revenue. This trend warrants close monitoring and analysis to understand the factors contributing to the lower profitability compared to previous years.
Peer comparison
Dec 31, 2023